Uncategorized

Heart disease remains the number 1 cause of death among individuals worldwide. To reduce this threat, a variety of screenings are used to monitor heart health, including blood tests to check levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL)…

The FDA recently approved the first tumor-infiltrating lymphocyte, or TIL, therapy to treat advanced melanoma, and 27 institutions have so far been authorized to deliver the treatment. 

Chicago-based Northwestern Medicine confirmed to Becker's that it filed applications with the state Feb. 15, seeking approval for a proposed $75 million expansion of its cancer center in Warrenville, Ill. 

Jonathan Uhr, MD, a medical researcher who expanded knowledge on antibodies and cancer treatments, died of prostate cancer on Feb. 15. He was 96, The Washington Post reported.

York, Pa.-based WellSpan Health is expanding vascular surgery services in four cities by adding four vascular surgeons and three satellite offices.

The National Institutes of Health has awarded funding to eight medical groups that will become part of its inaugural Cancer Screening Research Network, an effort to advance existing knowledge about emerging cancers, early detection and treatment, it announced Feb. 21.

The University of Cincinnati Cancer Center is the first site in the Midwest to launch a phase 2 clinical trial to test a pancreatic cancer vaccine.

Niacin, a common B vitamin once recommended to patients as a way to help lower cholesterol, has been linked to cardiovascular disease, Cleveland Clinic researchers announced Feb. 19. 

Francisco Esteva, MD, PhD, was appointed chief of hematology and medical oncology at three hospitals.

There may be a new tool in the arsenal of the fight against cancer — more specifically, in the fight against HPV-caused cancers, which do not respond as well to traditional treatment methods like chemotherapy or radiation.